Targeting Dopamine Receptor D2 By Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype
…to USC would aid in its management. However, few studies have focused solely on this rare subtype. The current study demonstrated that the orally bioavailable, investigational new drug and novel…
read more